Showing results (2871-2880 of 3,353) with videos related to
Sort By:
Pageof 336
Pharmacoeconomics|September 7, 2007
Preferences of community pharmacists for extended roles in primary care: a survey and discrete choice experimentAnthony Scott, Christine Bond, Jackie Inch, et al.Pharmacoeconomics|September 17, 2008
Costs and effects of secondary prevention with perindopril in stable coronary heart disease in Poland: an analysis of the EUROPA study including 1251 Polish patientsW Ken Redekop, Ewa Orlewska, Pawel Maciejewski, et al.Pharmacoeconomics|July 16, 2008
Modelling approaches: the case of schizophreniaBart M S Heeg, Joep Damen, Erik Buskens, et al.Pharmacoeconomics|July 16, 2008
Conducting discrete choice experiments to inform healthcare decision making: a user's guideEmily Lancsar, Jordan LouvierePharmacoeconomics|June 20, 2008
Pharmaceutical risk-sharing agreementsJoseph P Cook, John A Vernon, Richard ManningPharmacoeconomics|June 20, 2008
Pharmacoeconomic evaluations of pharmacogenetic and genomic screening programmes: a systematic review on content and adherence to guidelinesStefan Vegter, Cornelis Boersma, Mark Rozenbaum, et al.Pharmacoeconomics|September 25, 2007
Lessons from trial-based cost-effectiveness analyses of mental health interventions: why uncertainty about the outcome, estimate and willingness to pay mattersJeffrey S Hoch, Carolyn S DewaPharmacoeconomics|November 30, 2006
Association of co-morbidities with prescribing patterns and cost savings: olanzapine versus risperidone for schizophreniaWei Yu, Xinhua S Ren, Austin F Lee, et al.Pageof 336